Atlas Trials

Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3)

Clinical trial NCT02320474 · COMPLETED

Trial details

NCT number
NCT02320474
Sponsor
Poitiers University Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 3 Choroidal Neovascularization
Start date
2014-11-25
Primary completion
2018-11-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.